Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03657511 · ClinicalTrials.gov registry record · NA

Tobacco Cessation Intervention

A NA study of Smoking, Tobacco, sponsored by Barbara Ann Karmanos Cancer Institute.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03657511 is a NA study of Smoking, Tobacco that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 100 participants, below the 624-participant average among 18 other Smoking, Tobacco trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03657511, a NA study of Smoking, Tobacco, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study is planned as an evaluation of a low cost, simple smoking cessation intervention. There is very little information about the effectiveness of a simple tobacco cessation strategy. Therefore, our objective is to obtain estimates of effectiveness that can be used to refine existing programs or to develop new ones.

Conditions Studied

Interventions

  • BEHAVIORAL Educational Interventions to Promote Tobacco Cessation

Study Locations (1)

Michigan

  • Barbara Ann Karmanos Cancer Institute - Detroit

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-10-22
Est. Completion 2021-06-21
Phase NA

What the Registry Record Tells You About NCT03657511

The ClinicalTrials.gov registry entry for NCT03657511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 624-participant average among 18 other Smoking, Tobacco trials with a reported enrollment target (84% lower). The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking, Tobacco appearing as the primary indexed condition, and to 1 intervention - of which Educational Interventions to Promote Tobacco Cessation is the first listed.

NCT03657511 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03657511 about?

NCT03657511 is a clinical study titled "Tobacco Cessation Intervention". This study is planned as an evaluation of a low cost, simple smoking cessation intervention. There is very little information about the effectiveness of a simple tobacco cessation strategy. Therefore, our objective is to obtain estimates of effectiveness that can be used to refine existing programs ...

What is the current status of trial NCT03657511?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-10-22. Estimated completion is 2021-06-21.

What conditions does trial NCT03657511 study?

This clinical trial studies the following conditions: Smoking, Tobacco.

What interventions are being tested in trial NCT03657511?

The interventions under investigation include: Educational Interventions to Promote Tobacco Cessation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03657511?

This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03657511 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking, Tobacco

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.